Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 36 37 38 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AiCuris Anti-infective Cures GmbH. (1/31/18). "Press Release: Approval of MSD’s Prevymis (letermovir) by the European Commission Triggers the Next EUR 30 Million Milestone Payment for AiCuris". Wuppertal. 2018-01-31
Oncgnostics GmbH. (1/31/18). "Press Release: Reliable Test for Cervical Cancer Triage Now Available in Slovakia and the Czech Republic". Jena. 2018-01-31
Rentschler Biopharma SE. (1/31/18). "Press Release: Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer". Laupheim. 2018-01-31
Helsinn Healthcare S.A.. (1/30/18). "Press Release: Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement". Lugano. 2018-01-30
Creathor Venture Management GmbH. (1/30/18). "Press Release: Creathor Invests in E-Health Platform »Humanoo«". Berlin & Bad Homburg v.d.H.. 2018-01-30
BaseLaunch ( (1/30/18). "Press Release: BaseLaunch up to a Solid Phase II Start". Basel. 2018-01-30
Sanofi S.A.. (1/29/18). "Press Release: Sanofi to Acquire Ablynx for €3.9 Billion". Paris & Ghent. 2018-01-29
Merck KGaA. (1/26/18). "Press Release: Dirk Toepfer Joins Merck as Chief Information Officer". Darmstadt. 2018-01-26
Endress+Hauser AG. (1/26/18). "Press Release: Further Growth for Endress+Hauser in China. Third Plant Inaugurated in Suzhou". 2018-01-26
Novartis AG. (1/26/18). "Press Release: Advanced Accelerator Applications Receives FDA Approval for Lutathera for Treatment of Gastroenteropancreatic Neuroendocrine Tumors". Basel. 2018-01-26
Santhera Pharmaceuticals Holding AG. (1/26/18). "Press Release: Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone in Duchenne Muscular Dystrophy". Liestal. 2018-01-26
Roche. (1/26/18). "Press Release: CHMP Recommends EU Approval of Roche’s Hemlibra for People with Haemophilia A with Inhibitors". Basel. 2018-01-26
Illumina, Inc.. (1/26/18). "Press Release: Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2018-01-26
ThromboGenics N.V.. (1/26/18). "Press Release: Novartis Pharma AG Holding 5.69% of ThromboGenics Equity Capital". Leuven. 2018-01-26
Clariant. (1/25/18). "Press Release: SABIC Acquires 24.99% Stake in Clariant. SABIC Acquires Stakes Previously Held by 40 North and Corvex Management". Muttenz. 2018-01-25
PerkinElmer, Inc.. (1/25/18). "Press Release: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017". Waltham, MA. 2018-01-25
Topas Therapeutics GmbH. (1/25/18). "Press Release: Topas Therapeutics Serves as Exclusive Translational Partner for Collaborative Research Center Focused on Liver Inflammation at University Medical Center Hamburg-Eppendorf". Hamburg. 2018-01-25
Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel. 2018-01-24
Novartis AG. (1/24/18). "Press Release: Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US, a milestone for patients with rare inherited vision loss". Basel. 2018-01-24
ImmuPharma plc. (1/24/18). "Press Release: Successful Placing to Raise £10 Million". 2018-01-24
Qlucore AB. (1/24/18). "Press Release: Enhanced Collaboration between Qlucore and Nebion to Help Biologists Get More Out of Their Data Analysis". 2018-01-24
CureVac AG. (1/24/18). "Press Release: CureVac Expands Intellectual Property Position that Significantly Improves Protein Expression for its mRNA-Based Vaccines and Therapeutics". Tübingen. 2018-01-24
Genedata AG. (1/24/18). "Press Release: Genedata, HighRes Biosolutions, and Titian Software Collaborate for Automated End-to-End Screening Solution". Basel, Beverly, CA & London. 2018-01-24
Ablynx N.V.. (1/24/18). "Press Release: Ablynx Appoints Dr Robert Friesen as Chief Scientific Officer". Ghent. 2018-01-24
Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD. 2018-01-23
High-Tech Gründerfonds Management GmbH. (1/23/18). "Press Release: Dräger Invests in HTGF III". 2018-01-23
BCNP Consultants GmbH. (1/22/18). "Press Release: 23rd February Chemistry Industry Innovators from 27 Countries Will Meet at the 2nd European Chemistry Partnering". Frankfurt a. M.. 2018-01-22
Celgene Corporation. (1/22/18). "Press Release: Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy". Summit, NJ & Seattle, WA. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Completes Tender Offer for Advanced Accelerator Applications S.A. and Announces Commencement of Subsequent Offering Period". Basel. 2018-01-22
Novartis AG. (1/22/18). "Press Release: Novartis Reports Erenumab Met All Primary and Secondary Endpoints in Unique Phase IIIb Study in Episodic Migraine Patients Who Have Failed Multiple Prior Preventive Treatments". Basel. 2018-01-22
Genmab A/S. (1/22/18). "Press Release: Genmab Announces Novartis' Intention to Transition Arzerra (ofatumumab) from Commercial Availability to Limited Availability via Compassionate Use Programs for the Treatment of CLL in Non-US Markets". Copenhagen. 2018-01-22
Sanofi S.A.. (1/19/18). "Press Release: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee". Paris. 2018-01-19
Biotest AG. (1/19/18). "Press Release: All Conditions Met for Creat Takeover of Biotest". Dreieich. 2018-01-19
Qiagen N.V.. (1/18/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-01-18
Inositec AG. (1/18/18). "Press Release: Inositec AG Appoints Dr Frits van Alphen as Chief Medical Officer". Zurich. 2018-01-18
ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. 2018-01-18
Novartis AG. (1/18/18). "Press Release: Sandoz Announces Exclusive Global Collaboration with Biocon on Next-generation Biosimilars". Holzkirchen. 2018-01-18
Selexis S.A.. (1/17/18). "Press Release: Selexis SA Appoints Alberto Garotti as Chief Financial Officer". Geneva. 2018-01-17
Synpromics Ltd.. (1/17/18). "Press Release: Synpromics Appoints Sarah Haecker Meeks, PhD as Vice President of Business Development. Company Establishes U.S. Subsidiary to Expand Operations". Edinburgh. 2018-01-17
Novartis AG. (1/17/18). "Press Release: Novartis Granted US FDA Priority Review for Kymriah (tisagenlecleucel), formerly CTL019, for Adults with r/r DLBCL". Basel. 2018-01-17
Helmholtz-Zentrum München. (1/17/18). "Press Release: Innovative Antibody Production. Helmholtz Association Funding Spin-off". 2018-01-17
Immatics Biotechnologies GmbH. (1/17/18). "Press Release: Immatics Appoints Thomas Ulmer as Chief Financial Officer". Tübingen & Houston, TX. 2018-01-17
Novartis AG. (1/16/18). "Press Release: Novartis New Data Reinforces Superiority of Cosentyx versus Stelara in Achieving Skin Clearance for Psoriasis Patients". Basel. 2018-01-16
Novartis AG. (1/16/18). "Press Release: Sandoz Regulatory Submission for Proposed Biosimilar Adalimumab Accepted by FDA". Holzkirchen. 2018-01-16
Owkin. (1/16/18). "Press Release: Owkin Closes $11 Million Series A Financing Round". New York, NY. 2018-01-16
Merck KGaA. (1/16/18). "Press Release: Merck Presents Data on Bifunctional Immunotherapy M7824 at ASCO 2018 Gastrointestinal Cancers Symposium". Darmstadt. 2018-01-16
BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz. 2018-01-15
Roche. (1/12/18). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in the European Union for Relapsing Forms of Multiple Sclerosis and Primary Progressive Multiple Sclerosis". Basel. 2018-01-12
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". 2018-01-11
Novartis AG. (1/11/18). "Press Release: Novartis Appoints Elizabeth Barrett as Oncology Head". Basel. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate with Merck KGaA, Darmstadt, Germany, on a Novel Immuno-Oncology Combination for Ovarian Cancer". Menlo Park, CA. 2018-01-11
Forty Seven Inc.. (1/11/18). "Press Release: Forty Seven Inc. to Collaborate on a Novel Immuno-Oncology Combination for Leukemia and Bladder Cancer". Menlo Park, CA. 2018-01-11
Immunic AG. (1/11/18). "Press Release: FDA Approves IND for Immunic Therapeutics’ IMU-838 to Proceed with Phase 2 Study in Ulcerative Colitis". Planegg-Martinsried. 2018-01-11
Gilde Healthcare Partners. (1/11/18). "Press Release: Gilde Healthcare Opens Office in Frankfurt Germany". Utrecht & Frankfurt a. M.. 2018-01-11
Genedata AG. (1/11/18). "Press Release: Genedata Announces New Solution for CRISPR Data Management and Analysis". Basel. 2018-01-11
Sophia Genetics S.A.. (1/11/18). "Press Release: Sophia Genetics Appoints Valentin Matillon as New Chief Financial Officer". St. Sulpice. 2018-01-11
Enamine Ltd.. (1/10/18). "Press Release: Enamine Supplies DSI Poised Fragment and Analogue Libraries to Diamond Light Source XChem Facility and SGC Oxford Screening Efforts". Kiev & Oxford. 2018-01-10
Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel. 2018-01-10
Scancell Holdings plc. (1/9/18). "Press Release: Scancell to Collaborate with BioNTech to Investigate T cell Receptor based Therapeutics for the Treatment of Cancer". 2018-01-09
Novartis AG. (1/9/18). "Press Release: Novartis Advances Head-to-head Superiority Trials of Cosentyx versus Humira and Proposed Biosimilar Adalimumab". Basel. 2018-01-09
Boehringer Ingelheim. (1/9/18). "Press Release: BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab". Cambridge, MA, Beijing & China. 2018-01-09
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation Technology". Freising. 2018-01-09
Genedata AG. (1/9/18). "Press Release: Genedata Screener Raises the Bar on Automation in 2018". Basel. 2018-01-09
MLM Medical Labs GmbH. (1/9/18). "Press Release: New S1 Lab Expands MLM’s Service Portfolio". 2018-01-09
Cell Medica Ltd.. (8/1/18). "Press Release: Cell Medica Appoints New CEO to Drive CAR and TCR Clinical Development and Commercialisation". London & Houston, TX. 2018-01-08
Roche. (1/8/18). "Press Release: Roche and GE Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment". Basel. 2018-01-08
European Invesmtent Bank (EIB). (1/8/18). "Press Release: Investment Plan for Europe. EIB Grants Loan of EUR 40m to Indivumed". 2018-01-08
Evotec AG. (1/8/18). "Press Release: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi". Hamburg & Vienna. 2018-01-08
Imcyse S.A.. (1/8/18). "Press Release: Imcyse Announces a Research Collaboration with Pfizer Inc. in Rheumatoid Arthritis (RA)". Liège. 2018-01-08
BioNTech AG. (1/4/18). "Press Release: BioNTech Secures USD 270 Million in Series A Financing". Mainz. 2018-01-04
CureVac AG. (1/4/18). "Press Release: CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-mediated mRNA Therapeutics". Tübingen, Boston, MA & San Diego, CA. 2018-01-04
Miracor Medical S.A.. (1/4/18). "Press Release: Miracor Medical Raises €25m. Funds Will Be Used to Support Clinical and Prepare Commercial Activities – Company Relocates from Austria to Belgium". Awans & Vienna. 2018-01-04
Enterome S.A.. (1/4/18). "Press Release: Enterome Raises €32 Million ($38.5 Million) in a Series D Financing". Paris & Cambridge, MA. 2018-01-04
Rewind Therapeutics. (1/4/18). "Press Release: Rewind Therapeutics Secures 15.2m Euro to Develop Novel Remyelination Therapies". Leuven. 2018-01-04
Themis Bioscience GmbH. (1/4/18). "Press Release: Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline". Vienna. 2018-01-04
Roche. (1/4/18). "Press Release: Roche Launches the cobas Plasma Separation Card to Increase Access to HIV testing for Patients Living in Remote Areas". Basel. 2018-01-04
CRISPR Therapeutics AG. (1/4/18). "Press Release: CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-04
Cellestia Biotech AG. (1/4/18). "Press Release: First Patient Dosed in First-in-human Phase l-lla Clinical Study with Cellestia’s Proprietary, Protein-protein Interaction Inhibitor CB-103 Targeting the NOTCH Oncogenic Signalling Pathway in Cancer". Basel 2018-01-04
Oculis S.A.. (1/4/18). "Press Release: Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases". Lausanne. 2018-01-04
Biocrates Life Sciences AG. (1/3/18). "Press Release: Biocrates Life Sciences AG Acquires Metanomics Health GmbH to Create a New Global Leader in Metabolomics and Early Disease Detection". Innsbruck. 2018-01-03
Addex Therapeutics S.A.. (1/3/18). "Press Release: Addex and Indivior Sign Strategic Partnership to Accelerate Development of GABAB PAMs as Addiction Treatments". Geneva. 2018-01-03
Boehringer Ingelheim. (1/3/18). "Press Release: Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€". Ingelheim & Boston, MA. 2018-01-03
CRISPR Therapeutics AG. (1/3/18). "Press Release: CRISPR Therapeutics Announces Proposed Public Offering of Common Shares". Zug & Cambridge, MA. 2018-01-03
Clariant. (1/2/18). "Press Release: Clariant and Global Bioenergies Unveil Development of New Bio-based Cosmetics Polymer for More Natural Formulations". Muttenz & Evry. 2018-01-02
Bruker Corporation. (12/31/17). "Press Release: Bruker Announces Merger of Japan Subsidiaries". Yokohama. 2017-12-31
Roche. (12/22/17). "Press Release: Roche and Ignyta Reach Definitive Merger Agreement. Roche to Acquire Ignyta for US$ 27.00 per Share". Basel. 2017-12-22
Roche. (12/22/17). "Press Release: Roche Commences Tender Offer for All Shares of Ignyta, Inc. for US$ 27.00 per Share in Cash". Basel. 2017-12-22
Helmholtz-Zentrum München. (12/22/17). "Press Release: Launch of Helmholtz Center Munich’s Stem Cell Center". 2017-12-22
GeNeuro S.A.. (12/21/17). "Press Release: GeNeuro To Receive €12 Million Milestone Payment from Servier for Final Patient Visit in GNbAC1 CHANGE-MS Phase 2b Study". Geneva. 2017-12-21
CRISPR Therapeutics AG. (12/21/17). "Press Release: CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board". Zug & Cambridge, MA. 2017-12-21
Genedata AG. (12/20/17). "Press Release: Genedata Profiler Moves To High-performance Clouds". Basel. 2017-12-20
Merck KGaA. (12/20/17). "Press Release: Merck Signs Commercial Supply Agreement with Bluebird Bio for Viral Vector Manufacturing". Darmstadt. 2017-12-20
Merck KGaA. (12/20/17). "Press Release: Merck Collaborates with iCON to Offer BioReliance End-to-End Turnkey Modular MAb Manufacturing Platform". Burlington, MA. 2017-12-20
Idorsia Ltd.. (12/20/17). "Press Release: Idorsia Forms Research Collaboration with Roche in the Field of Cancer Immunotherapy". Allschwil. 2017-12-20
PerkinElmer, Inc.. (12/19/17). "Press Release: PerkinElmer Completes Acquisition of Euroimmun". Waltham, MA. 2017-12-19
Genedata AG. (12/19/17). "Press Release: Genedata Screener Celebrates 15 Years of Increasing In-Vitro Screening Efficiency at Global Pharmas, Biotechs, and CROs". Basel. 2017-12-19
Merck KGaA. (12/19/17). "Press Release: Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology". Darmstadt. 2017-12-19
Confo Therapeutics N.V.. (12/19/17). "Press Release: Confo Therapeutics Enters into Drug Discovery Collaboration with Roche". Ghent. 2017-12-19
Bruker Corporation. (12/19/17). "Press Release: Bruker Celebrated the 100th Customer of Its Newly Introduced Tracer 5i Handheld XRF Elemental Analyzer Optimized for Advanced Applications and Research at Pennsylvania State University". Kennewick, WA. 2017-12-19
DiCE Molecules SV, Inc.. (12/19/17). "Press Release: DiCE Molecules Announces Multi-Year Research Collaboration with Genentech". San Francisco, CA. 2017-12-19
next pagenext page 1 2 3 ... 36 37 38 ... 67 68 69  next pagenext page


Picture [iito] Männer Ballett 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch GmbH GMP Basic Course Online 650x300px

» top